GHA
PFE icon

Good Harbor Advisors’s Pfizer PFE Stock Holding History

Good Harbor Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.09M Sell
86,952
-770
-0.9% -$20.1K 2.05% 14
2026
Q1 		$2.46M Buy
87,722
+25
+0% +$666 2.69% 13
2025
Q4 		$2.18M Buy
+87,697
New +$2.21M 2.54% 13

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Good Harbor Advisors's PFE Position: Q2 2026 in Review

Good Harbor Advisors reduced its Pfizer (PFE) stake by 0.88% in Q2 2026, selling an estimated $20.1K and leaving 86,952 shares worth $2.09M. The position accounts for 2.05% of the portfolio, ranked #14.

Good Harbor Advisors first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.46M in Q1 2026. 2,815 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Good Harbor Advisors held 86,952 shares of Pfizer worth $2.09M as of Q2 2026.
  • Good Harbor Advisors sold 770 Pfizer shares in Q2 2026, an estimated $20.1K.
  • Pfizer made up 2.05% of Good Harbor Advisors's portfolio in Q2 2026, its #14 holding.
  • Good Harbor Advisors first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Good Harbor Advisors's Pfizer position peaked at $2.46M in Q1 2026.
  • 2,815 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Good Harbor Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.